Your browser doesn't support javascript.
loading
Myeloma bone disease: pathogenesis and management in the era of new anti-myeloma agents.
Teramachi, Jumpei; Miki, Hirokazu; Nakamura, Shingen; Hiasa, Masahiro; Harada, Takeshi; Abe, Masahiro.
Afiliación
  • Teramachi J; Department of Hematology, Endocrinology and Metabolism, Tokushima University Graduate School of Biomedical Sciences, 3-18-15 Kuramoto, Tokushima, 770-8503, Japan. jumptera@okayama-u.ac.jp.
  • Miki H; Department of Oral Function and Anatomy, Graduate School of Medicine Dentistry and Pharmaceutical Sciences, Okayama University Graduate School, 2-5-1 Shikata, Okayama, 700-8525, Japan. jumptera@okayama-u.ac.jp.
  • Nakamura S; Division of Transfusion Medicine and Cell Therapy, Tokushima University Hospital, Tokushima, Japan.
  • Hiasa M; Department of Community Medicine and Medical Science, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
  • Harada T; Department of Hematology, Endocrinology and Metabolism, Tokushima University Graduate School of Biomedical Sciences, 3-18-15 Kuramoto, Tokushima, 770-8503, Japan.
  • Abe M; Department of Orthodontics and Dentofacial Orthopedics, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
J Bone Miner Metab ; 41(3): 388-403, 2023 May.
Article en En | MEDLINE | ID: mdl-36856824

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedades Óseas / Mieloma Múltiple Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Humans Idioma: En Revista: J Bone Miner Metab Asunto de la revista: METABOLISMO Año: 2023 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedades Óseas / Mieloma Múltiple Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Humans Idioma: En Revista: J Bone Miner Metab Asunto de la revista: METABOLISMO Año: 2023 Tipo del documento: Article País de afiliación: Japón